Tigecycline Products Market Size Share Trends Forecast 2027

1. TIGECYCLINE PRODUCTS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Tigecycline Products Market - Overview Global Tigecycline Products Market: Regional Analysis On the basis of region, the global Tigecycline Products Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In North America, the demand for use of tigecycline is increasing due to high prevalence of chlamydia trachomtis. For instance, according to the Centers for Disease Control and Prevention, in 2016, 1,598,354 cases of chlamydia trachomatis infection were reported in the U.S., and 497.3 cases per 100,000 were reported in 2015. Therefore, pharmaceutical companies are focusing on product launches for the treatment of bacterial infectious disease. Tigecycline is an antibiotic available under brand name Tygacil which is used to treat serious bacterial infections such as urinary tract infections, acne, gonorrhea, and chlamydia. Tigecycline is used as an alternative agent for the treatment of resistant gram positive and gram negative infection, especially in patients with a history of penicillin allergy or antimicrobial related toxicities. Moreover, tigecycline binds to bacterial ribosomes and prevents bacterial ribosomes from producing cell protein needed for bacterial growth and multiplication but does not kill bacteria. Tigecycline is administrated through intravenous infusion over 30 to 60 minutes and initial dose of tigecycline for bacterial infection treatment is 100 mg followed by 50 mg every 12 hour. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/tigecycline-products-market-4168 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Tigecycline Products Market: Drivers The increasing prevalence of gonorrhea in the U.S. is driving demand for tigecycline products in the market. For instance, according to the Centers for Disease Control and Prevention’s 2017 report, in the U.S, around 555,608 cases of gonorrhea were reported. Therefore, pharmaceutical companies are focusing on launching products for treatment of bacterial infections due to increasing prevalence. For instance, in 2017, Sandoz Inc. launched AP-rated generic version of Tygacil (Tigecycline) injection at a cheaper price compared to branded products in order to increase affordability of the drug. These factors are expected to drive growth of global tigecycline products market. Global Tigecycline Products Market: COVID-19 Impact Analysis The COVID-19 pandemic has affected several markets across the globe. Pharmaceutical companies are facing difficulties such as regulatory revisions, changes in demand, delay in generic medicine approvals, disruption in supply chain, and product exportation restriction due to lockdown policies implementedby governments. Global Tigecycline Products Market: Restraints Tigecycline antibiotic is characterized by side effects such as lower back or side pain, painful or difficult urination, problems with vision or hearing, cough or hoarseness, fever or chills, and headache. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4168 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION In Europe, there is major burden of chlamydia and gonorrhea due to increasing prevalence. For instance, according to the National Health Service’s 2018 report, in England, over 44,500 people were diagnosed with gonorrhea in men and women of age under 25 in 2017. Therefore, pharmaceutical companies are focusing on launching product for treatment of bacterial infectious diseases. For instance, in February 2020, European Medicines Agency approved marketing authorization of tigecycline injection by Accord Healthcare for treatment of bacterial skin diseases. These factors are expected to drive growth of the global tigecycline products market during the forecast period. Global Tigecycline Products Market: Key Players Key players operating in the global tigecycline products market are Amneal Pharmaceuticals, Inc., Novartis International AG, Xellia pharmaceuticals ApS, Accord Healthcare Inc., Apotex, Inc., Aurobindo Pharma Limited, Fresenius Kabi USA LLC, Pfizer Inc., Abbott Laboratories, and AstraZeneca plc. Moreover, patients prefer oral tablets (amoxicillin) to injection (tigecycline) for treatment of bacterial infection, due to the cost effectiveness of oral amoxicillin. Cost of 500 mg amoxicillin oral tablet is US$ 23.99, while cost of the tigecycline injection is US$ 79.22. These factors are expected to restrain growth of the global tigecycline products market Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4168 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved